[ Price : $8.95]
An Axios report following the resignation of CDER director George Tidmarsh questions how much more agency dysfunction industry can...[ Price : $8.95]
Sarepta Therapeutics reports mixed data from its Phase 3 ESSENCE confirmatory study evaluating its Duchenne muscular dystrophy dru...[ Price : $8.95]
Compass Pathways says it expects to be able to launch its COMP360 psilocybin treatment for treatment-resistant depression nine to ...[ Price : $8.95]
Otsuka ICU Medical recalls (Class 1) one lot of its potassium chloride injection, 20 mEq, after discovering that the overwrap labe...[ Price : $8.95]
FDA gives investigative device exemption approval for an Aqua Medical pilot clinical trial of its Proximal Intestinal Mucosal Abla...[ Price : $8.95]
A new report from the Reagan-Udall Foundation calls for broad operational and policy reforms to improve the efficiency, representa...[ Price : $8.95]
Aurinia Pharmaceuticals lawsuit against CDER director George Tidmarsh includes screenshots of troubling text messages and emails f...[ Price : $8.95]
CDER director George Tidmarsh resigns after being placed on administrative leave amid an internal ethics investigation and a defam...